← All medicines

Cancer medicines

Neratinib

Independent educational summary · Sources checked November 20, 2026

A targeted treatment for selected HER2-positive breast cancers, with the regimen depending on prior therapy and disease stage.

Profile scope: Neratinib. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Diarrhea, abdominal discomfort, mouth ulcers, appetite loss and nail changes may occur.

Serious risks and warning signs

Severe diarrhea can lead to dehydration and requires the oncology team's prevention and treatment plan. Liver injury is another important risk; jaundice, dark urine or upper-right abdominal pain needs prompt advice.

A question for your healthcare team

What diarrhea-prevention plan and liver-test schedule should I follow, and which acid-reducing medicines interfere with treatment?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.